Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
BioNews - BioPortfolio's News Portal
Drug Development News and Headlines
Sign-up to BioPortfolio's
Drug Development news alerts
.
Subscribe to
Drug RSS feed
-
-
View full RSS Index
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
Idera Pharmaceuticals Reports First Quarter 2008 Financial Results
Yahoo!:
similar ...
Diagnosis: Cancer, but hope evolving
Topeka Capital-Journal:
similar ...
Chronic fatigue syndrome clinical practice guidelines 2002
The Medical Journal of Australia:
similar ...
HAART Can Eliminate HIV Mother-To-Child Transmission (MTCT). Properly Timed Effective Use of HAART Can Prevent
National AIDS Treatment Advocacy Project:
similar ...
GenVec, Inc. Q1 2008 Earnings Call Transcript
Yahoo!:
similar ...
CORRECTING and REPLACING Progenics Pharmaceuticals Reports First Quarter 2008 Results
Yahoo!:
similar ...
CORRECTING and REPLACING Progenics Pharmaceuticals Reports First Quarter 2008 Results
Genetic Engineering News:
similar ...
Progenics Pharmaceuticals Reports First Quarter 2008 Results
SmartBrief:
similar ...
Progenics Pharmaceuticals Reports First Quarter 2008 Results
Yahoo!:
similar ...
Meet the Meds: TheBody.com Gets the Lowdown on CCR5 Inhibitors
The Body:
similar ...
BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
Yahoo!:
similar ...
Myriad Genetics, Inc. F3Q08 (Qtr. End 03/31/08) Earnings Call Transcript
Seeking Alpha:
similar ...
Meda AB (publ), January - March 2008 interim report
Calibre Macro World:
similar ...
AstraZeneca Submits sNDA For SYMBICORT For COPD Indication
Pharmaceutical Online:
similar ...
Myriad Genetics Reports Results for Third Quarter of Fiscal 2008
TMC Net:
similar ...
Some Data, Little Direction on How to Treat Older Women with Breast Cancer
Oncology Times:
similar ...
Roche's Investigational Hepatitis C Polymerase Inhibitor, R1626, Demonstrated Significant End-of-Treatment Res
Medical News Today:
similar ...
Three Studies Presented At 43rd EASL Showed Higher SVR For PEGASYS(R) (Peginterferon Alfa-2a) Plus Ribavirin T
Medical News Today:
similar ...
Three Studies Presented at 43rd EASL Showed Higher SVR for PEGASYS(R) (Peginterferon Alfa-2a) Plus Ribavirin T
KOTA Territory News:
similar ...
Interim Results From Boceprevir Phase II Study In Genotype 1 Treatment-Naive Hepatitis C Patients Presented At
Medical News Today:
similar ...
